• A. Eggermont - ESMO 2020

    PRESS RELEASE: KEYTRUDA® (pembrolizumab) Reduced the Risk of Distant Metastasis or Death by 40% Compared Versus Placebo as Adjuvant Treatment in Resected, High-Risk Stage III Melanoma

  • Benjamin Besse - ESMO 2020
    Categories: ,

    New Data Gives Hope to Small Cell Lung Cancer Patients

  • ESMO 2020
    Categories:

    EORTC abstracts selected at ESMO 2020 Virtual Congress

  • researcher with a microscope
    Categories:

    New Kid on the block in cancer therapy- the tumour microenvironment

  • GDPR - European General Data Protection Regulation
    Categories:

    GDPR in the scope of clinical research and secondary use of data: EMA discussion paper

  • The brain tumour patients' charter of rights

    PRESS RELEASE: Advocacy Organizations and Professional Societies from Across the Globe Unite on Brain Tumour Patients’ Charter of Rights

  • covid-19
    Categories:

    COVID19 and its impact on clinical cancer research: the EORTC network experience

  • Laure Fournier from EORTC Imaging group

    Impact of COVID-19 crisis on imaging in oncological trials